Brief: Hoth Therapeutics Announces Engagement With Icon And Expansion Of Phase Ii Clinical Trial For Ht-001 In Europe
29/07/2025 14:30
July 29 (Reuters) - Hoth Therapeutics Inc HOTH.O: HOTH THERAPEUTICS ANNOUNCES ENGAGEMENT WITH ICON AND EXPANSION OF PHASE II CLINICAL TRIAL FOR HT-001 IN EUROPE HOTH THERAPEUTICS INC - TO EXTEND PHASE II TRIAL OF HT-001 IN EU Source text: ID:nPn76TSGfa Further company coverage: HOTH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rocket One
See all newsBrief: Rocket One Signs AI Chip Development Agreement Targeting Ultra-Low-Power Magnetic Computing
Brief: Rocket One Signs Agreement To Advance Nanomagnetic Ai Chip Technology And Device Prototyping
Brief: Rocket One Signs Patent License Agreement With U.S. Air Force For Technology Designed To Capture And Neutralize Hostile Drones
Brief: Rocket One To Buy 100% Ownership Of Tracer Drone Technologies
Brief: Rocket One And Nasa Reach Agreement To Advance Space Ai Technology